Loading clinical trials...
Loading clinical trials...
This study will be conducted to observe the difference in microbiome composition between healthy participants and inflammatory bowel disease (IBD) participants with no anti-tumor necrosis factor (anti...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Eisai Korea Inc.
NCT04844606 · Ulcerative Colitis, Ulcerative Colitis Chronic, and more
NCT06483373 · Inflammatory Bowel Disease
NCT06810518 · Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis), Inflammatory Bowel Syndrome
NCT06553053 · Crohn's Disease Relapse, Inflammatory Bowel Diseases
NCT07385807 · IBD (Inflammatory Bowel Disease), IBD, and more
Eisai Trial Site # 1
Seoul
Eisai Trial Site # 2
Seoul
Eisai Trial Site # 3
Seoul
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions